The GOP Doctors Caucus, a group of medical doctors serving in Congress, endorsed the PBM Reform Act (H.R.4317) on Tuesday. The bill addresses NCPA legislative priorities that were in the original Continuing Resolution package from December 2024. Reps. Greg Murphy (R-N.C.) and John Joyce (R-Pa.), who co-chair the caucus, expressly called out PBMs in a statement as driving up the cost of lifesaving drugs.
"Reform is long overdue to rein in the abuse of PBMs, which prioritize profits over patients through shady practices such as pushing high-cost drugs, limiting consumer access, monopolizing the market, and reimbursing pharmacies at unacceptable rates. This legislation will make much-needed reforms to put patients first,” they said.
This legislation saves taxpayers $5 billion and reins in PBM abuses to pharmacies by eliminating spread pricing, requiring reasonable reimbursement in Medicaid managed care, requiring reasonable and relevant Medicare Part D contracts, and creating an avenue for pharmacies to report Part D Contract violations. This endorsement highlights that all providers understand that we need PBM reform now!
NCPA thanks Murphy, Joyce, and the entire caucus for endorsing this priority legislation introduced by Rep. Buddy Carter (R-Ga.) earlier this year. The endorsement highlights that providers serving in Congress understand the urgency of PBM reform!
To learn more about the PBM Reform Act, click here.
